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Platelet-derived growth factor is a major proliferative
and migratory stimulus for connective tissue cells dur-
ing the initiation of skin repair processes. In response to
injury, locally produced platelet-derived growth factor
is secreted by a diversity of cutaneous cell types whereas
target activity is con¢ned to cells of mesenchymal ori-
gin, e.g. dermal ¢broblasts and smooth muscle cells.
Although epidermal cells contribute to cutaneous plate-
let-derived growth factor activity by their ample capa-
city to secrete platelet-derived growth factor ligand,
normal epidermal keratinocytes are not known to ex-
press any member of the platelet-derived growth factor
receptor family. In order to study if epidermis may be
genetically transformed to a platelet-derived growth
factor sensitive compartment we aimed to introduce
the gene encoding human platelet-derived growth fac-
tor receptor b (PDGFbR) into epidermal keratinocytes
using a retrovirus-derived vector. Successful gene trans-
fer to primary cells was con¢rmed by immuno£uores-
cence staining, southern blotting, and ligand-induced
receptor autophosphorylation. By culturing a mixture
of PDGFbR-transduced and unmodi¢ed keratinocytes
at the air^liquid interface on devitalized dermis, we
were able to establish a multilayered epithelium show-
ing histologic similarities to that evolved from native
keratinocytes or keratinocytes transduced with the
reporter gene encoding enhanced green £uorescent
protein. Receptor-modi¢ed epidermal tissue cultured
for 6 days and examined by immuno£uorescence mi-
croscopy was shown to contain PDGFbR-expressing
keratinocytes distributed in all layers of living epider-
mis. By continued tissue culture in serum-containing
medium, the epidermis became increasingly corni¢ed
although receptor-positive cells were still observed
within the viable basal compartment. Stimulation of
PDGFbR-transduced epidermis with recombinant pla-
telet-derived growth factor BB had a mitogenic e¡ect
as re£ected by an increased frequency of Ki-67 positive
keratinocytes. The study demonstrates that transgene
expression of human PDGFbR can be achieved in epi-
dermal keratinocytes by retroviral transduction, and
that ligand activation of such gene-modi¢ed skin
equivalent enhances cell proliferation. In perspective,
viral PDGFbR gene transfer to keratinocytes may be a
useful approach in studies of receptor tyrosine kinase
mediated skin repair and epithelialization. Key words:
genetic transduction/green-£uorescent protein/PDGF receptor
tyrosine kinase/wound healing/proximity ligation. J Invest
Dermatol 120:742 ^749, 2003
S
kin tissue repair is regulated by intrinsic peptides such as
platelet-derived growth factor (PDGF), a mitogenic hor-
mone secreted at sites of trauma. Locally released PDGF
attracts monocytes, promotes neovascularization, and
stimulates connective tissue cells to proliferate, migrate,
and synthesize extracellular matrix components. Together with
platelets and macrophages from the circulation, a multitude of
cells residing in human skin, e.g. keratinocytes, endothelial cells,
¢broblasts, and smooth muscle cells, contribute to PDGF pro-
duction in the injured microenvironment (reviewed in Heldin
and Westermark, 1999). Mesenchymal cells in the skin express
PDGF-speci¢c cell surface receptors, which convey autocrine or
paracrine responses via activation of the signal transduction net-
work (Heldin et al, 1981; Reuterdahl et al, 1993). Under physiologic
conditions, epidermal cells do not express transmembrane recep-
tors recognizing any classical PDGF isoform (AA, AB, and BB
dimers); thus target cells for these ligands in normal skin seem
restricted to dermal constituents exclusively.
Animal data indicate that delayed skin repair is associated with
reduced expression of both PDGF ligands and their correspond-
ing receptors (Beer et al, 1997). Hence, attempts have been made
to stimulate cutaneous healing by boosting the PDGF activity in
the wound environment (Moulin et al, 1998). Human studies in
diabetic lower extremity ulcer (Steed, 1995; Embil et al, 2000;
Margolis et al, 2000) and decubital ulcer (Robson et al, 1992) have
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shown that topical administration of recombinant PDGF-BB
promotes granulation tissue and vascular formation. The clinical
achievements of exogenous PDGF therapy, however, are rather
modest and require that the peptide be applied repeatedly in
pharmacologic concentrations during a considerable length of
time (Wieman et al, 1998; Rees et al, 1999). In search of a more
con¢ned and durable delivery of PDGF at the exact location
of tissue repair, a collagen-embedded PDGF-B DNA plasmid
(Tyrone et al, 2000) or a viral vector containing the PDGF-B gene
(Liechty et al, 1999; Breitbart et al, 2001) were found to improve
dermal healing in rabbit ischemic ulcers. Similarly, grafting of
PDGF-A-transduced human skin to athymic mice was reported
to reduce wound contraction (Eming et al, 1998) and to stimulate
blood vessel formation and dermal cellularity (Eming et al, 1995).
Supp and colleagues, on the other hand, found no evidence of a
dermal response from retroviral PDGF-A gene transfer in mice
(Supp et al, 2000).
Hitherto, gene-therapeutic approaches using PDGF in wound
healing have focused mainly on the ligand rather than the recep-
tor, and primarily on dermis rather than epidermis. To potentiate
the e¡ect of PDGF-mediated skin repair ^ including reepithelia-
lization ^ one can hypothesize that it might be therapeutically
advantageous to make adjacent epidermis sensitive to PDGF sti-
muli. With the aim of converting human epidermis to a target
tissue for PDGF stimulation, we have introduced the PDGFbR
gene to normal epidermal keratinocytes by a retrovirus-mediated
technique. Gene-modi¢ed keratinocytes were used as a source to
establish a receptor-positive skin equivalent responsive to recom-
binant PDGF-BB by enhanced cell proliferation similarly to
nonepithelial cells expressing endogenous PDGFbR.
MATERIALS AND METHODS
Retroviral vectors and packaging cell lines A 3.4 kb cDNA
encoding human PDGFbR (Claesson-Welsh et al, 1988) was cloned into
the retroviral vector GCsam (Chuah et al, 1995), which drives transgene
expression from a Moloney murine leukemia virus long-terminal repeat
(MoMLV LTR). The vector was packaged in PG13 cells as described
previously (Onodera et al, 1997). DNA was transfected into the ecotropic
packaging cell line GPþE 86 (Markowitz et al, 1990) by calcium
phosphate coprecipitation (Mammalian Transfection Kit, Stratagene, La
Jolla, CA). Supernatant from transfected cells was harvested after 24 h,
supplemented with polybrene at 8 mg per ml, passed through a 0.45 mm
¢lter, and used to transduce PG13 cells subsequently cloned by limiting
dilution. After 15 d, 10 PG13 clones were analyzed for vector production
by a screening technique similar to that described previously (Jensen et al,
1997). The supernatant was transferred onto cultured keratinocytes prior to
immuno£uorescence staining using a monoclonal PDGFbR antibody (as
below). One PG13 clone out of 10 tested was positive and was used for
further experiments.
The retroviral vector GCsamGFP was constructed by inserting the
enhanced green £uorescent protein (eGFP) gene, isolated from pEGFP-
N1 (Clontech, Palo Alto, CA), into the GCsam retroviral vector.
GCsamGFP was packaged in PG13 cells as described above. Transduced
PG13 cells were cloned by limiting dilution, 10 of which were analyzed
for vector production after 15 d by measuring the GFP £uorescence of
target keratinocytes using £ow cytometry. The PG13 clone yielding the
strongest GFP £uorescence of target cells was used for further experiments.
Culture and transduction of primary keratinocytes Normal human
keratinocytes (NHK) were obtained from neonatal foreskin samples and
cocultured with lethally irradiated 3T3 feeder cells (Rheinwald and
Green, 1975) in ‘‘classical medium’’, i.e., a 3:1 mixture of Dulbecco’s
modi¢ed Eagle’s medium and Ham’s F-12 nutrient medium,
supplemented with 10% fetal bovine serum, hydrocortisone (0.5 mg per
ml), cholera enterotoxin (10^10 M), epidermal growth factor (EGF, 10 ng
per ml), insulin (5 mg per ml), penicillin (100 IU per ml), streptomycin
(100 mg per ml), adenine (1.810^4 M), and nonessential amino acids. The
keratinocytes were subcultivated in ‘‘serum-free medium’’, i.e., Gibco’s
keratinocyte-SFM basal medium supplemented with gentamycin (5 mg
per ml) plus attached recombinant EGF (0.1^0.2 ng per ml) and bovine
pituitary extract (25 mg per ml). Second passage keratinocytes were
transduced at 60% con£uency as described by Garlick et al (1991).
Polybrene (8 mg per ml) in 20 mM HEPESHCl pH 7.4 was added to
fresh supernatant from packaging cell lines cultivated at 371C, and passed
through a 0.45 mm ¢lter. Keratinocytes, plated inT-75 £asks the day before
transduction, were exposed to 2 ml retroviral supernatant for 2 h at 371C
with intermittent gentle agitation. The supernatant was then removed and
the keratinocytes were maintained in serum-free medium until analyzed or
used for raft cultures.
For immuno£uorescence and blotting studies, porcine aortic endothelial
(PAE) cells were used as negative controls, whereas PAE cells stably
transfected with the PDGFbR gene served as positive controls (Claesson-
Welsh et al, 1988). The PAE cells were grown in F-10 medium (Gibco)
containing 10% fetal bovine serum.
Immuno£uorescence and £ow cytometry of transduced cells
Keratinocyte cultures grown on chamber slides were examined by
immuno£uorescence microscopy as described previously (Jensen et al,
1996) using a monoclonal PDGFbR antibody (RDI-PDGFRBabm,
Research Diagnostics, Flanders, NJ) reactive with the extracellular
domain of the receptor subunit (Hart et al, 1987). The primary antibody
(1:200 dilution) was applied to living cells maintained on ice for 30 min.
After ¢xation in neutral bu¡ered 10% formalin, the secondary £uorescent
antibody Alexa Fluor 488 goat antimouse IgG (Molecular Probes, Leiden,
The Netherlands) was applied at 1:200 dilution for 15 min. Nuclear
staining was performed with Hoechst 33258 before £uorescence
microscopy. Cultured cells were also analyzed in a Leica TCS confocal
laser scanning microscope using propidium iodide for nuclear staining.
Flow cytometry was performed with a FACS Calibur £ow £uorimeter
(Becton Dickinson). GFP and propidium iodide were excited at 488 nm
and analyzed at 514 nm (FL1) and 546 (FL2), respectively.
Southern blotting Southern blotting procedures were performed as
described previously (Sambrook et al, 1989). Genomic DNA was isolated
and digested with the restriction enzyme Nhe I. Five micrograms of
DNA was electrophoresed on a 0.7% agarose gel and blotted to a
Magnacharge membrane (Frisenette, Ebeltoft, Denmark). The membrane
was hybridized with a 32P random labeled 3.4 kb PDGFbR cDNA probe.
Phosphotyrosine immunoblotting Cell cultures were placed on ice
and exposed to human recombinant PDGF-BB (generous gift from
Amgen, CA) at 100 ng per ml in phosphate-bu¡ered saline (PBS),
supplemented with bovine serum albumin (BSA) at 1mg per ml or PBS
alone, for 60 min before preparing a cell lysate. A WGA Sepharose
(Pharmacia, Uppsala, Sweden) fraction was analyzed by sodium dodecyl
sulfate polyacrylamide gel electrophoresis separation and immunoblotted
using a phosphotyrosine antibody (PY20) and a PDGFbR antibody
(P-20) purchased from Santa Cruz Biotechnology (Santa Cruz, CA).
Antibodies were detected by chemiluminescence using a sheep antimouse
secondary antibody conjugated to horseradish peroxidase, NA931
(Amersham Pharmacia Biotech, Stockholm, Sweden).
Radioreceptor assay Con£uent keratinocyte cultures in 12-well plates
(approximately 2.6105 cells per well) were incubated on ice for 90 min
with a mixture of 5 ng per ml of 125I-labeled PDGF-BB (speci¢c activity
12,250 cpm per m) plus unlabeled recombinant PDGF-BB (Amgen) at
concentrations ranging between 0 and 1000 ng per ml. Binding of
radiolabeled ligand was analyzed in duplicate using a radioreceptor assay
(Heldin et al, 1988).
PDGF-BB assay The concentration of PDGF-BB was measured using
proximity-ligation assay allowing detection of zeptomole amounts of
ligand (Fredriksson et al, 2002).
Formation of gene-modi¢ed epidermis at the air^liquid interface
Virally transduced keratinocytes were used to generate a multilayered
epithelium with deepidermized dermis (DED) as substrate (Freeman et al,
1976; Regnier et al, 1990). DEDs were obtained from normal skin at breast
reduction surgery and prepared according to Rikimaru et al (1997). At
culture, raft-like supports for the DEDs were prepared from Cell Strainer
cups (Becton Dickinson Labware, Franklin Lakes, NJ) by cutting o¡ the
lateral linings and dividing the vertical plastic ribs at 5 mm distance from
the horizontal nylon mesh. Two 33 mm fenestrations were made in the
mesh (70 mm pore size) to ensure su⁄cient medium exchange. The
modi¢ed Cell Strainers were placed, one each per well, in 6-well culture
plates. The DEDs (one to three per well) were placed onto the mesh and
then fresh classical medium (containing PDGF-BB at 0.07 pM or 2 pg per
ml as determined by the PDGF-BB assay) was added to the upper level of
the DED. Keratinocytes (genetically unmodi¢ed, PDGFbR-transduced,
and GFP-transduced, respectively) were collected by centrifugation and a
‘‘pellet’’ containing 105 cells suspended in 15 ml medium was placed on top
of the DEDs for air^liquid interface culture. Parallel cultures were grown
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in ‘‘EGF-de¢cient medium’’ (i.e., classical medium with no added EGF)
supplemented or not with 25 ng per ml of recombinant PDGF-BB. Cells
were allowed to attach for 10 min and then incubated in 5% CO2 in
humidi¢ed air at 371C. The culture medium (as above) was replaced every
3 d. Analysis of the PDGF-BB content of conditioned classical (PDGF-BB
unsupplemented) medium showed values ranging between 0.05 and
0.3 pM (1.5^9.0 pg per ml). Cultured cells were examined for green
£uorescence using an Olympus SZX12 stereomicroscope equipped with a
100 W mercury lamp, a coaxial £uorescence illuminator, and a built-in
GFP ¢lter cube. At harvest on days 6 or 16, tissues were either snap frozen
in OTC compound (Tissue-Tek, Miles,Torrance, CA) for storage at 701C
or ¢xed in 4% paraformaldehyde.
Morphology and immunohistochemical staining of epidermal
reconstructs Para⁄n-embedded tissue sections were stained with
hematoxylineosin for routine histology. Immunohistochemical analysis
using anti-involucrin antibody CLA130 (BioSite, Stockholm, Sweden) at
1:1000 dilution was performed on 5 mm sections with biotinylated
antimouse IgG (1:80 dilution) as secondary antibody. Visualization was
with the standard avidinbiotin-coupled immunoperoxidase technique
(Vectastain ABC kit,Vector Laboratories, Burlingame, CA).
To quantify proliferative cells in para⁄n-embedded specimens, three
parallel sections (20 mm apart) were obtained from the tissue center,
microwaved 35 min at 750 W in 10 mM citrate bu¡er pH 6.0, blocked
with 10% normal rabbit serum for 15 min, and incubated with
the monoclonal mouse anti-Ki-67 antibody MIB-1, 1:50 dilution
(Immunotech, Marseille, France), at þ 41C for 10 h. As secondary
antibody, biotinylated antimouse IgG, 1:80 dilution, was added 30 min
prior to incubation with avidinbiotinperoxidase complex. The enzyme
reaction was developed with 3-amino-9-ethylcarbazole. In each coded
section, the number of Ki-67 positive cells was counted in three
randomly selected visual ¢elds by the same microscopist. The number of
stained cells in the basal or adjacent suprabasal position was related to the
area of viable epidermis and to the length of the basement membrane zone,
respectively, using a Leica DM RB microscope equipped with a Leica DC
200 digital camera and Q500 image analysis software (Leica Microsystems).
The mean number of Ki-67 positive cells in each sample was obtained by
averaging mean values from the three sections. The thickness of epidermis
was measured at the horizontal midpoint of each visual ¢eld.
Immuno£uorescence microscopy of epidermal reconstructs The
expression of GFP in cryosections was examined using a Leica
£uorescence microscope equipped with a green £uorescence ¢lter.
Immuno£uorescence was performed on acetone-¢xed 6 mm cryosections
using monoclonal antikeratin 14 (LL002, 1:50 dilution; Novocastra
Laboratories, Newcastle-upon-Tyne, U.K.), antikeratin 1 (clone LHK1, 1:10
dilution, generous gift of I.M. Leigh) and antikeratin 16 (LL0025, 1:50
dilution, generous gift of I.M. Leigh). Alexa Fluor 594 (Molecular Probes,
Leiden, The Netherlands) was used as secondary £uorescent antibody at
1:800 dilution. PDGFbR immuno£uorescence on acetone-¢xed sections
was performed by blocking with 10% normal horse serum for 15 min,
exposure to the primary antibody (RDI-PDGFRBabm as speci¢ed above)
at 1:1600 dilution for 10 h at þ 41C, and incubation with biotinylated
mouse IgG at 1:200 dilution for 30 min prior to staining with £uorescent
Texas Red avidin conjugate (Vector Laboratories, Burlingame, CA) at 1:100
dilution for 30 min. Nuclear staining was with Hoechst 33258 (Molecular
Probes) added to the mounting medium. Negative controls were prepared
by omitting the primary antibody. The proportion of PDGFbR-positive
cells relative to Hoechst-labeled cells in the epidermis was determined by
£uorescence microscopy using ¢lters optimized for rhodamine (excitation
at 54675 nm; barrier ¢lter at 590 nm) and Hoechst dye.
Statistics Statistical analysis was performed using ANOVA random
e¡ects applying a mixed model (SAS/STAT software, SAS Institute, Cary,
NC).
RESULTS
PDGFbR gene integration and expression by cultured
keratinocytes The PDGFbR gene was retrovirally transferred
to primary keratinocytes as veri¢ed by southern blotting
analysis of genomic DNA from transduced cells. The DNAwas
isolated and digested with Nhe I, which cleaves in each LTR
sequence of the vector, but not in the transgene. The southern
blot was hybridized with a PDGFbR cDNA probe. As seen in
Fig 1(c), the PDGFbR-transduced cells yielded a band with the
expected size (5.3 kb) indicating the presence of an integrated
vector in the host cells. On average, keratinocytes transduced
with the PDGFbR gene contained approximately one copy of
the transgene.
The expression of PDGFbR protein was veri¢ed by indirect
immuno£uorescence of living cells using a speci¢c monoclonal
antibody against the extracellular domain of the human
PDGFbR subunit. Flow cytometry analysis showed that 42% of
the cells in culture were transduced with the PDGFbR gene.This
is less e⁄cient than commonly achieved by retroviral gene
transfer and is probably due to the relatively high density (60%
con£uency) of keratinocytes at the time of transduction.
PDGFbR-immunopositive cells in monolayer culture displayed
a lucent £uorescence of the cell surface (Fig 1b) with some
additional granular staining suggesting that the antibody also
recognizes intracellular epitopes. The membrane pattern of
receptor £uorescence was more evident using confocal laser
scanning microscopy (results not shown). Control stainings
of GFP-transduced and genetically unmodi¢ed (Fig 1a)
keratinocytes did not reveal any immunostaining using the
PDGFbR antibody.
Competitive radioactive PDGF labeling and Scatchard analy-
sis demonstrated that PDGFbR-transduced cells expressed
approximately 160,000 receptors per cell with a binding a⁄nity
Kd of 0.4 nM (results not shown).
Autophosphorylation of the PDGF receptor by ligand
stimulation Immunoblot analysis of lysates prepared from
PDGFbR-transduced cells yielded a 180 kDa band
corresponding to the size of mature PDGFbR (Fig 2). There
were no detectable bands corresponding to the precursor form
(164 kDa) or smaller proteins, which have been recognized
by Western blot analysis of dermal ¢broblasts (Hart et al,
1987). Phosphotyrosine blotting of PDGFbR-transduced cells
stimulated with recombinant PDGF-BB showed receptor
autophosphorylation con¢rming that the receptor was activated
by ligand exposure.
Visualization of reporter gene expression by £uorescence
microscopy of GFP-transduced cells and tissue reconstructs
Fluorescence microscopy of GFP-transduced keratinocytes in
culture showed a distinct cytoplasmatic signal in a majority
(470%) of cells in monolayer culture. A bright green
£uorescence was maintained during subsequent air^liquid
interface culture as seen by vital microscopy and also
demonstrated in cryosections of GFP-transduced epidermal
tissue (Fig 3).
The morphology and di¡erentiation marker patterns are
similar in normal and PDGFbR-modi¢ed epidermal
reconstructs The overall tissue architecture of normal and
gene-modi¢ed epidermis grown in classical medium for 6 d was
similar in all types of DED-based raft cultures. As shown in
Fig 3, a strati¢ed and well-organized epithelium displaying all
light microscopy layers typical of normal human epidermis was
established at the air^liquid interface. After 16 d in culture, tissue
morphology of all samples changed markedly in that a compact
stratum corneum covering one to three layers of viable
keratinocytes was developed. This feature, which is characteri-
stic of air-exposed classical epidermal cultures (Regnier et al,
1990), was equally prominent in all three types of tissues
studied. Immuno£uorescence microscopy showed that the
di¡erentiation-speci¢c marker keratin 1 (Ponec et al, 1997) was
similarly expressed in normal versus gene-modi¢ed epidermis
cultured under classical conditions. The staining pattern of
involucrin was also comparable ^ irrespective of keratinocyte
source ^ and localized in the upper epidermal layers (results not
shown). Cytokeratin 14 protein was expressed not only by basal
keratinocytes, as found in normal skin (Stoler et al, 1988), but
also in the suprabasal layers of viable epidermis. This is a
hallmark of hyperproliferative epidermis such as psoriasis lesions
(Castelijns et al, 1999) and skin equivalents generated with the
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raft technique (Rikimaru et al, 1997). Furthermore, the
hyperproliferative marker, keratin 16, was expressed within
the entire viable epidermis and stained similarly regardless of the
origin of the keratinocytes (results not shown).
PDGFbR expression in gene-modi¢ed epidermis The
expression of PDGFbR by transduced keratinocytes was studied
both in monolayer cultures and in reconstituted epidermis using
immunostaining techniques. The proportion of PDGFbR-
expressing cells did not change over time from the initial phase
of monolayer culture (42% positive cells by £uorescence-
activated cell sorter analysis) to the subsequent stage of
air-exposed multilayered cultures when examined by
immuno£uorescence microscopy. In cryosections of PDGFbR-
transduced epidermis, receptor-positive keratinocytes ^ both
single and clustered ^ were displayed between non£uorescent
epidermal areas. In 6-d-old cultures, there was a bright
membrane pattern of receptor staining by cells representing all
epidermal levels (Fig 3). By 16 d in culture, the fraction of
PDGFbR-expressing cells was di⁄cult to assess due to the
pronounced accumulation of epidermal squames in all samples
examined. The density of receptor-positive cells in the more
basal, undi¡erentiated layers, however, indicated that the
percentage of PDGFbR-expressing cells was largely unchanged
in late-stage cultures grown under classical conditions.
Figure1. PDGFbR transgene integration is expressed by transduced
keratinocytes in culture. Indirect immuno£uorescence of (a) un¢xed
normal and (b) PDGFbR-transduced keratinocytes cultured on chamber
slides and stained with antihuman PDGFbR primary antibody and Alexa
Fluor 488 secondary antibody. Nuclear staining was performed using pro-
pidium iodide. (c) Southern blotting analysis of genomic DNA isolated
from PDGFbR-transduced (left lane), untransduced (middle lane), and GFP-
transduced (right lane) keratinocytes digested with Nhe I, electrophoresed,
and hybridized with radiolabeled PDGFbR cDNA probe. A 5.3 kb frag-
ment with the expected size of the transgene is seen in the left lane.
Figure 2. PDGFbR is autophosphorylated following ligand stimu-
lation. WGA fractions of keratinocyte (NHK) and control cell (PAE)
lysates were electrophoresed, transferred to nitrocellulose, and probed with
antihuman PDGFbR antibody as described in Materials and Methods. Cell
lysates from PDGFbR-transduced keratinocytes (GCsamPDGFbR/NHK)
show strong expression of 180 kDa PDGFbR (upper panel, lanes 5, 6), and
receptor autophosphorylation following recombinant PDGF-BB stimula-
tion (lower panel, lane 6). Positive control cells transfected with the
PDGFbR gene (PDGFbR/PAE) show a weak receptor signal (upper panel,
lanes 1, 2) and a strong phosphotyrosine signal (lower panel, lane 2) after li-
gand exposure. Untransfected control PAE cells (ctr/PAE) and GFP-trans-
duced keratinocytes (GCsamGFP/NHK) show neither receptor nor
phosphotyrosine signaling (lanes 3, 4 and 7, 8, respectively).
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Epidermal reconstructs expressing the PDGFbR transgene
respond to ligand stimulation by increased frequency of
cycling cells Normal and gene-modi¢ed epidermal cultures
were established in classical medium (with no added
recombinant PDGF-BB) containing low concentrations of
natural PDGF-BB (o9 pg per ml conditioned medium). After 6
and 16 d, respectively, in tissue culture the samples were sectioned
and immunohistochemically stained with the Ki-67 antibody. As
shown in Fig 4, the proportion of proliferative cells in the three
types of epidermis was almost identical. Taken together, the mean
(7SEM) numbers of Ki-67 positive cells per millimeter
basement membrane length were 3874 (day 6) and 1172 (day
16, not shown), respectively. Moreover, no di¡erence in Ki-67
frequency was observed between normal and gene-modi¢ed
epidermis cultured in EGF-de¢cient medium devoid of recom-
binant PDGF-BB. When stimulated with recombinant PDGF-
BB (25 ng per ml medium), however, the frequency of Ki-67
positive cells increased signi¢cantly in PDGFbR-transduced
Figure 3. Epidermal morphology and immunostaining patterns in PDGFbR-transduced tissues are similar to the situation in genetically
unmodi¢ed reconstructs. Epidermis was regenerated from untransduced (left), GFP-transduced (middle), and PDGFbR-transduced (right) keratinocytes
(NHK) cultivated in classical keratinocyte medium (with EGF, without recombinant PDGF-BB) for 6 d. Haematoxylineosin stained sections of all re-
constructs displayed similar morphologic features (¢rst row). Cryosections of GFP-transduced tissue showed an intense epidermal signal by £uorescence
microscopy (second row). By immuno£uorescence, PDGFbR-transduced tissue showed positive receptor staining using a PDGFbR antibody visualized with
Texas Red avidin secondary antibody (third row). Immunostainings of keratin 1 (fourth row), keratin 14 (¢fth row), and Ki-67 antigen (not shown) displayed
comparable patterns between all tissues. Magni¢cation: 250 .
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epidermis (5172.8 cells per mm) compared to GFP-transduced
(3373.1, po0.05) or unmodi¢ed (2272.0, po0.001) tissue.
Comparable results were obtained if the number of Ki-67
positive cells was normalized to the area of viable epidermis.
The proportion of cycling cells in PDGFbR-transduced
epidermis was even higher when cultured with recombinant
PDGF (without added EGF) than in classical medium
supplemented with EGF. Also, when receptor-positive
reconstructs were stimulated with recombinant PDGF, a slightly
thicker epithelium (mean 94.8 mm) developed compared to
unmodi¢ed controls (mean 84.7 mm); the di¡erence, however,
was not statistically signi¢cant. It should be noted that the
density of cycling cells was somewhat higher in the GFP-
transduced epidermis compared to untransduced tissue if related
to length of basement membrane (po0.05), but nonsigni¢cant if
related to the viable epidermal area.
DISCUSSION
PDGF is a key regulator in cutaneous tissue repair and synthe-
sized from ligand-producing cells at the site of injury. Although
secreted rather ubiquitously from skin cells and thrombocytes,
the main target cells for receptor-mediated PDGF activity are
dermal constituents recognizing various peptide isoforms.
PDGF-BB interacts with both a- and gb-receptor subtypes, and
represents a potent ligand in terms of connective tissue response.
As a result, PDGF-BB binding induces dermal cells to proliferate
and migrate, thus promoting granulation tissue formation. Ana-
logously, wound healing stimulation by gene-modi¢ed keratino-
cytes overexpressing the PDGF-B gene has been shown to induce
cell-rich connective tissue repair in athymic mice (Eming et al,
1999). Human keratinocytes are major contributors to endogen-
ous PDGF-AA secretion but these cells do not seem to secrete
other proteins belonging to the classical PDGF receptor family
(Ansel et al, 1993). Despite some production of PDGFbR tran-
scripts by highly di¡erentiated keratinocytes in culture (Teumer
et al, 1994) and injured pig skin (Antoniades et al, 1991), the exis-
tence of PDGF receptor type b on NHK has not yet been
demonstrated (Rubin et al, 1988; Ansel et al, 1993).
In this study, epidermal keratinocytes were transformed into
PDGF-responsive cells using a retroviral vector. Radioreceptor
assay and Scatchard analysis indicated that recombinant PDGF-
BB was bound to cells expressing the transmembrane receptor
with an approximate Kd of 0.4 nM and an estimated receptor
density of 1.6105 per keratinocyte. These results correspond to
values obtained with human ¢broblasts expressing the endogen-
ous PDGFbR (stman et al, 1989).
As £ow cytometry demonstrated that PDGFbR gene transfer
e⁄cacy was 42%, the epidermal reconstructs were initiated from
a mixture of keratinocytes, a majority of which did not express
the receptor. Accordingly, cryosections of gene-modi¢ed epi-
dermis showed a patchy appearance representing 30%^50%
PDGFbR-immunopositive cells by day 6. This indicates that the
normal and gene-modi¢ed cells expanded similarly in classical
medium containing less than 0.3 pM of natural PDGF-BB. In
many sections, there was a tendency to a clustered distribution of
receptor-positive cells in successive layers suggesting that trans-
duced keratinocytes and neighboring daughter cells expressed the
transgene. During short-term culture there was no obvious survi-
val advantage ^ or disadvantage ^ of PDGFbR-transduced cells
when cultured under classical (recombinant PDGF-BB unsupple-
mented) conditions. After 16 d in culture the proportion of
PDGFbR-expressing cells was di⁄cult to assess due to the predo-
minance of stratum corneum (showing no receptor staining) at
this stage of air-exposed culture.The basal cell compartment, how-
ever, showed persistent £uorescence from receptor-expressing cells.
The raft culture model is a valuable tool in biologic studies of
multilayered epidermis (Regnier et al, 1990). As opposed to ani-
mal models based on gene-modi¢ed cells or tissue grafts, the
in vitro situation facilitates controlled application of bioactive
compounds without ample contribution from other sources. As
a fundamental point of this study was to assess proliferative activ-
ity within the gene-modi¢ed epithelium itself rather than the
surrounding tissues. Thus, we maintained reconstituted epidermis
in vitro (with a de¢ned PDGF-BB environment) instead of per-
forming subsequent transplantation (in vivo) procedures.We used
devitalized dermis as substrate, epidermal keratinocytes as the
single source of cells, and classical growth medium with a low
background level ranging between 1.5 and 9.0 pg per ml of
PDGF-BB. Using the raft model, we found no detrimental e¡ects
from retroviral exposure on the architecture, short-term survival,
or di¡erentiation-speci¢c marker expression in transduced epi-
dermal tissues. The various reconstructs cultured in classical med-
ium did not show any apparent di¡erences in their keratin or
involucrin immuno£uorescence patterns. It should be emphasized
that reconstituted epidermis grown on rafts is more proliferative
than native skin, particularly during the ¢rst week in culture
(Gibbs et al, 2000). This is in accordance with the hyperprolifera-
tive state of our equivalents when grown in classical medium
containing EGF. Accordingly, the hyperproliferation-associated
keratin 16 and the basal keratin 14 were both expressed fairly
homogeneously across the viable compartment as judged by im-
muno£uorescence microscopy. A reason why basal keratin 14 is
expressed suprabasally may be that the transcript is not degraded
rapidly enough to abolish the protein signal from these regions of
hyperproliferative epidermis (Castelijns et al, 1999).
Ligand binding to endogenous PDGFbR is known to induce
autophosphorylation of the tyrosine kinase receptor and subse-
quent activation of the signal transduction network leading to
increased proliferation and mobility of target cells. In this study,
receptor phosphorylation and growth promotion was induced by
Figure 4. PDGFbR-positive epidermis responds to recombinant
PDGF-BB stimulation by increased proliferation. Keratinocyte cul-
tures were established at the air^liquid interface on DEDs and stained im-
munohistochemically using the proliferation marker Ki-67. Upper panel:
the frequency of Ki 67 positive cells per millimeter basement membrane
length in untransduced (left bar), GFP-transduced (middle), and PDGFbR-
transduced (right) epidermis cultured in classical medium (containing less
than 9 pg per ml of PDGF-BB) for 6 d. Lower panel: the frequency of Ki-
67 positive cells normalized to basement membrane length (left histogram) or
viable epidermal area (right histogram) in 6-d-old epidermal reconstructs
grown in classical medium (minus EGF) supplemented with recombinant
PDGF-BB at 25 ng per ml. Means 7 SEM (n¼ 24 ¢elds per cell type).
npo0.05; nnpo0.01.
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ligand exposure to cells expressing the PDGFbR transgene. In
native epidermis, the proliferative activity is usually restricted to
the basal cell layer and recognizable, e.g., by using antibodies
against the Ki-67 antigen expressed by cycling cells. In our three
di¡erent skin equivalents cultured under classical conditions
(with no recombinant PDGF in the medium) there were similar
frequencies of Ki-67 positive cells although some cycling cells
were also displayed at the adjacent suprabasal level.When stimu-
lated with recombinant PDGF-BB at 25 ng per ml (a concentra-
tion 42500 times higher than that of endogenous PDGF-BB in
classical medium), however, the density of proliferative cells was
signi¢cantly increased in PDGFbR-transduced tissue compared
to GFP-transduced and untransduced equivalents. Hypothetically,
the PDGFbR-expressing epidermal cells may have responded to
PDGF protein from diverse sources: autocrine stimulation by
transduced cells, paracrine stimulation by neighboring keratino-
cytes, and medium-derived stimulation by natural or exogenous
ligand. Recombinant ligand was probably the predominant
source as the concentrations of PDGF-BB, the natural isoform
to which PDGFbR is preferentially receptive, are much lower or
even undetectable in skin tissue (Grayson et al, 1993; Cooper et al,
1994), cultured keratinocytes (Ansel et al, 1993), and culture med-
ium (this study). Application of recombinant PDGF at 25 ng per
ml resulted in a 2.3-fold increase in the density of Ki-67 positive
cells compared to untransduced controls. The results are analo-
gous to those in a previous gene transfer study where human
EGFR, another transmembrane receptor with tyrosine kinase ac-
tivity, induced hyperproliferation and enhanced reepithelializa-
tion of porcine skin wounds (Nanney et al, 2000). The relevance
of the ¢nding that the GFP construct seems to give some back-
gound activity is uncertain as the di¡erence in Ki-67 density be-
tween untransduced and GFP-transduced tissues is very close to
the 0.05 signi¢cance level, and even nonsigni¢cant when related
to epidermal area.There are a few reports, however, claiming that
GFP may a¡ect mammalian cells (Hanazono et al, 1997; Liu et al,
1999). More speci¢cally, GFP gene transfer has been associated
with rapidly growing transfectants (Gubin et al, 1999; Migliaccio
et al, 2000).
In summary, we show that NHK in culture are amenable to
viral PDGFbR gene delivery and that these cells can be utilized
to produce a gene-modi¢ed epidermal reconstruct. We also de-
monstrate that ligand stimulation of such engineered tissue
stimulates the mitogenic activity implying that a functional tyr-
osine kinase receptor and downstream signal transduction path-
ways are operative. If future studies con¢rm that the
proliferative response is maintained also under in vivo conditions,
then this novel gene expression by keratinocytes might be
exploited in slow healing ulcer states where PDGF protein levels
are downregulated (Shukla et al, 1998). Although a link between
overexpressed PDGF receptor stimulation and tumor develop-
ment deserves further consideration, retrovirus-mediated intro-
duction of PDGFbR to epidermal cells may be a useful tool in
forthcoming strategies to modify keratinocyte proliferation and
epithelialization via a tyrosine kinase receptor.
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